Epac Mediates a cAMP-to-PKC Signaling in Inflammatory Pain: An Isolectin B4(+) Neuron-Specific Mechanism

Journal of Neuroscience - Tập 25 Số 26 - Trang 6119-6126 - 2005
Tim Hucho1, Olayinka A. Dina2,3, Jon D. Levine2,3
1National Institutes of Health Pain Center, University of California, San Francisco, San Francisco, California 94143, USA.
2National Institutes of Health Pain Center, University of California, San Francisco, 521 Parnassus Avenue, P.O. Box 0440, San Francisco, California 94143.
3National Institutes of Health Pain Center, University of California, San Francisco, San Francisco, California 94143

Tóm tắt

The ϵ isoform of protein kinase C (PKCϵ) has emerged as a critical second messenger in sensitization toward mechanical stimulation in models of neuropathic (diabetes, alcoholism, and cancer therapy) as well as acute and chronic inflammatory pain. Signaling pathways leading to activation of PKCϵ remain unknown. Recent results indicate signaling from cAMP to PKC. A mechanism connecting cAMP and PKC, two ubiquitous, commonly considered separate pathways, remains elusive. We found that, in cultured DRG neurons, signaling from cAMP to PKCϵ is not mediated by PKA but by the recently identified cAMP-activated guanine exchange factor Epac. Epac, in turn, was upstream of phospholipase C (PLC) and PLD, both of which were necessary for translocation and activation of PKCϵ. This signaling pathway was specific to isolectin B4-positive [IB4(+)] nociceptors. Also, in a behavioral model, cAMP produced mechanical hyperalgesia (tenderness) through Epac, PLC/PLD, and PKCϵ. By delineating this signaling pathway, we provide a mechanism for cAMP-to-PKC signaling, give proof of principle that the mitogen-activated protein kinase pathway-activating protein Epac also stimulates PKC, describe the first physiological function unique for the IB4(+) subpopulation of sensory neurons, and find proof of principle that G-protein-coupled receptors can activate PKC not only through the G-proteins αqand βγ but also through αs.

Từ khóa


Tài liệu tham khảo

2000, J Neurosci, 20, 4680, 10.1523/JNEUROSCI.20-12-04680.2000

2001, J Neurosci, 21, 6933, 10.1523/JNEUROSCI.21-17-06933.2001

1998, J Neurosci, 18, 3059, 10.1523/JNEUROSCI.18-08-03059.1998

10.1038/374272a0

2003, Biochem Soc Trans, 31, 83, 10.1042/bst0310083

10.1126/science.290.5489.124

10.1016/S0896-6273(00)80813-2

10.1038/365403a0

10.1038/24884

2000, J Neurosci, 20, 8614, 10.1523/JNEUROSCI.20-22-08614.2000

10.1016/S0306-4522(01)00425-0

10.1016/S0896-6273(03)00473-2

10.1111/j.1460-9568.2004.03169.x

10.1146/annurev.physiol.64.081501.155903

10.1038/ncb874

1998, J Neurosci, 18, 10345, 10.1523/JNEUROSCI.18-24-10345.1998

10.1146/annurev.neuro.20.1.399

10.1046/j.1460-9568.1999.00503.x

10.1038/35053509

10.1074/jbc.271.40.24962

10.1091/mbc.E03-05-0295

10.1016/S0306-4522(03)00400-7

10.1016/S0306-4522(03)00203-3

10.1126/science.282.5397.2275

10.1074/jbc.M403604200

10.1016/0306-4522(94)00423-3

1999, J Neurophysiol, 81, 1104, 10.1152/jn.1999.81.3.1104

10.1016/S0896-6273(00)80837-5

10.1073/pnas.061020198

10.1016/S0168-0102(01)00293-0

10.1515/bchm3.1996.377.6.373

10.1074/jbc.272.7.4637

10.1002/(SICI)1096-9861(19970519)381:4<428::AID-CNE3>3.0.CO;2-4

10.1016/S0896-6273(00)80966-6

10.1126/science.1071550

10.1126/science.1411571

10.1074/jbc.C200104200

10.1046/j.1460-9568.2003.02626.x

10.1016/S0306-4522(03)00267-7

10.1016/j.pain.2004.10.021

10.1093/emboj/19.4.496

1999, J Pharmacol Exp Ther, 288, 428

10.1083/jcb.200209105

10.1074/jbc.M306292200

10.1016/S0163-7258(02)00170-5

10.1038/ncb1101-1020

10.1016/0092-8674(92)90553-O

1989, J Biol Chem, 264, 20940, 10.1016/S0021-9258(19)30027-4

10.1016/S0962-8924(02)02294-8

10.1124/jpet.103.060350

10.1016/0006-8993(89)90929-3

1991, J Biol Chem, 266, 15771, 10.1016/S0021-9258(18)98476-0

2002, J Neurosci, 22, 4057, 10.1523/JNEUROSCI.22-10-04057.2002